Breaking News

Ascend, EW Healthcare Partner to Expand U.S. Capacity and Capabilities

Advanced BioScience Laboratories will become part of Ascend, expanding fill/finish capacity in the U.S.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Ascend Advanced Therapies, a gene-to-GMP development partner, has partnered with EW Healthcare Partners to expand the footprint and capabilities of the company in the U.S. and to continue investing further in infrastructure. Advanced BioScience Laboratories (ABL), a biotherapy, oncolytic and viral vector CDMO located in Rockville, MD, a portfolio company of EW Healthcare Partners, will become part of Ascend. EW will also make a significant capital investment in Ascend to support continued growth...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters